In 2014, upon evaluation needs for IBD patients and health care providers, IBD Unit specialists at the University of Alberta and the University of Calgary, collaboratively developed the IBD Clinical Care Pathways (IBD CCPs©)

They are structured, standardized, evidence-based multidisciplinary management algorithms, identifying an appropriate sequence of clinical interventions and timeframes for IBD patients

These IBD CCPs© are supported by systematic reviews of published evidence and are comprised of protocols, algorithms, and checklists that help to harmonize clinical and administrative aspects and ensure continuity of IBD care in outpatient setting

Optimal management of IBD flare, including complains and history assessment, timelines and laboratory/diagnostic imaging investigations

Safe induction of Biologic therapy

Appropriate management of patients biologic therapy, including optimization, maintenance and follow-up timelines

Informed family planning and safety during pregnancy

Management of IBD patients on no immunosuppressants or biologic therapy, follow-up timelines

Management of systemic steroid therapy, including induction, maintenance, withdrawal, and side-effects monitoring

Appropriate initiation and use of immunomodulators (thiopurines and methotrexate)

Highlights of indications and important timelines for surveillance

Provide direction regarding choice of therapy for patients with Crohn’s disease

Achieve and maintain remission with biologic therapy

Provide direction to management of patients with perianal Crohn’s disease

Provide direction for management of patients with Crohn’s disease after a bowel resection

Provide direction regarding choice of therapy for patients with ulcerative colitis

Supplemental Material

Biological therapy Summary

Comprehensive collection of biologics- and biosimilars-related documents and forms

To contact the clinical care pathway team please email: